Successful Treatment of Chronic Lymphocytic Leukemia Multifocal Central Nervous System Involvement with Ibrutinib

Turk J Haematol. 2018 May 25;35(2):147-149. doi: 10.4274/tjh.2017.0313. Epub 2018 Feb 2.

Authors

Anna Christoforidou¹, Georgios Kapsas², Zoe Bezirgiannidou¹, Spyros Papamichos¹, Ιoannis Kotsianidis¹

Affiliations

¹ Democritus University of Thrace, Department of Hematology, Alexandroupolis, Greece.
² Democritus University of Thrace, Department of Radiology, Alexandroupolis, Greece.

No abstract available

Keywords: CNS Ibrutinib.; Central nervous system; Chronic lymphocytic leukemia.

Publication types

Case Reports

MeSH terms

Adenine / analogs & derivatives
Agammaglobulinaemia Tyrosine Kinase
Aged
Central Nervous System / drug effects*
Central Nervous System / pathology
Central Nervous System Neoplasms / drug therapy*
Central Nervous System Neoplasms / pathology
Central Nervous System Neoplasms / secondary*
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
Piperidines
Protein Kinase Inhibitors / therapeutic use*
Protein-Tyrosine Kinases / antagonists & inhibitors*
Pyrazoles / therapeutic use*
Pyrimidines / therapeutic use*

Substances

Piperidines
Protein Kinase Inhibitors
Pyrazoles
Pyrimidines
ibrutinib
Protein-Tyrosine Kinases
Agammaglobulinaemia Tyrosine Kinase
Adenine